Implanon users are less likely to be satisfied with their contraception after 6 months than IUD users

Contraception

Volumn 80, Issue 5, 2009, Pages 452-456

  Wong, Renee C ^a   Bell, Robin J ^b   Thunuguntla, Kalyani ^a   McNamee, Kathleen ^c   Vollenhoven, Beverley ^a,d  

^a Women's and Children's Program   (Australia)

^b MONASH UNIVERSITY MEDICAL SCHOOL   (Australia)

^c Family Planning Victoria   (Australia)

^d MONASH UNIVERSITY   (Australia)

Author keywords

Contraception satisfaction; Copper T380A; Implanon; Intrauterine device; Mirena

Indexed keywords

ETONOGESTREL; LEVONORGESTREL;

ACNE; ADOLESCENT; ADULT; ARTICLE; BLEEDING; CLINICAL TRIAL; CONTRACEPTION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUNSELING; DEVICE REMOVAL; FAMILY PLANNING; FEMALE; FOLLOW UP; HUMAN; INFECTION; INTRAUTERINE CONTRACEPTIVE DEVICE; LIBIDO DISORDER; MOOD DISORDER; NORMAL HUMAN; PAIN; PATIENT SATISFACTION; PROSPECTIVE STUDY; QUESTIONNAIRE; SIDE EFFECT; WEIGHT GAIN;

ADOLESCENT; ADULT; CHOICE BEHAVIOR; COHORT STUDIES; CONTRACEPTION; CONTRACEPTION BEHAVIOR; CONTRACEPTIVE AGENTS, FEMALE; DESOGESTREL; DRUG IMPLANTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTRAUTERINE DEVICES; MENSTRUAL CYCLE; MENSTRUATION DISTURBANCES; MIDDLE AGED; PATIENT SATISFACTION; PROSPECTIVE STUDIES; QUESTIONNAIRES; VICTORIA; YOUNG ADULT;

EID: 70349934163     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.contraception.2009.03.021     Document Type: Article

References (17)

1. Sergent F., Clamageran C., Bastard A.M., Verspyck E., and Marpeau L. Acceptability of the etonorgestrel-containing contraceptive implant (Implanon). J Gynecol Obstet Biol Reprod (Paris) 33 (2004) 407-415
2. Rai K., Gupta S., and Cotter S. Experience with Implanon in a north-east London family planning clinic. Eur J Contracep Reproduc Health Care 9 (2004) 39-46
3. Reuter S., and Smith A. Implanon: user views in the first year across three family planning services in the Trent Region, UK. Eur J Contracep Reproduc Health Care 8 (2003) 27-36
4. Radesic B., and Sharma A. Levonorgestrel-releasing intrauterine system for treating menstrual disorders: a patient satisfaction questionnaire. Aust N Z J Obstet Gynaecol 44 (2004) 247-251
5. Sivin I., and Stern J. Health during prolonged use of levonorgestrel 20 micrograms/d and the copper TCu380Ag intrauterine contraceptive devices: a multicentre study. Fertil Steril 61 (1994) 70-77
6. Australian Bureau of Statistics Census of Population and Housing: Basic Community Profile, 2006 (2007), Commonwealth of Australia, Canberra
7. Richters J., Grulich A.E., de Visser R.O., Smith A.M., and Rissel C.E. Sex in Australia: contraceptive practices among a representative sample of women. Aust N Z J Public Health 27 (2003) 210-216
8. PBS Statistics Medicare Australia. Australian Government. Available from. http://www.medicareaustralia.gov.au/provider/pbs/stats.jsp
9. Medicare Australia Statistic. Medicare Australia. Australian Government. Available from. https://www.medicareaustralia.gov.au/statistics/mbs_item.shtml [accessed 30 December 08]
10. Weisberg E., and Fraser I. Australian women's experience with Implanon. Aust Fam Physician 34 (2005) 694-696
11. Flores J., Balderas M., Bonilla M., and Vazquez-Estrada L. Clinical experience and acceptability of the etonogestrel subdermal contraceptive implant. Int J Gynaecol Obstet 90 (2005) 228-233
12. Diaz J., Bahamondes L., Monteiro I., et al. Acceptability and performance of the levonorgestrel-releasing intrauterine system (Mirena) in Campinas, Brazil. Contraception 62 (2000) 59-61
13. Backman T., and Huhtala S. Sixty thousand women-years of experience on the levonorgestrel intrauterine system: an epidemiological survey in Finland. Eur J Contracep Reproduc Health Care 6 Suppl 1 (2001) 23-26
14. 2 and the frameless levonorgestrel-releasing intrauterine system. Contraception 70 (2004) 173-177
15. Lei Z.W., Wu S.C., Garceau R.J., et al. Effect of pretreatment counseling on discontinuation rates in Chinese women given depo-medroxyprogesterone acetate for contraception. Contraception 53 (1996) 357-361
16. Hubacher D., Goco N., Gonzalez B., and Taylor D. Factors affecting continuation rates of DMPA. Contraception 60 (1999) 345-351
17. Canto De Cetina T.E., Canto P., and Ordoñez Luna M. Effect of counseling to improve compliance in Mexican women receiving depot-medroxyprogesterone acetate. Contraception 63 (2001) 143-146